We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for elexacaftor/tezacaftor/ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)
Active ingredients
elexacaftor/tezacaftor/ivacaftor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Granules
Indication
For the treatment of cystic fibrosis (CF)
Therapeutic area
Respiratory